ArticleJAC-antimicrobial resistance2021
Resistance mechanisms and genetic relatedness among carbapenem-resistant
Article in JAC-antimicrobial resistance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 14 citations in OpenAlex.
- Global epidemiology of carbapenem-resistantJAC-antimicrobial resistance · 2026Review
- Role of Cefiderocol in the Treatment of Carbapenem-Resistant Nonfermenting Gram-Negative Bacilli (Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia) Infections: An Expert Statement.Infectious diseases and therapy · 2026Article
- First report of a urinaryFrontiers in microbiology · 2026Article
- First report of a DIM-1-producingAntimicrobial agents and chemotherapy · 2025Article
- Antimicrobial Resistance Mechanisms in Carbapenem-ResistantPolish journal of microbiology · 2025Article
- Distribution of Carbapenemase Genes Associated With Global High-Risk Sequence Types in Pseudomonas aeruginosa Isolates From Chronic Leg Ulcer Patients in Northern Tanzania.International wound journal · 2025Article
- High-riskHeliyon · 2025Article
- Revisiting the Metallo-International journal of microbiology · 2025Review
- Worldwide Dissemination ofAntibiotics (Basel, Switzerland) · 2023Review
- Characterization of a mobilizable megaplasmid carrying multiple resistance genes from a clinical isolate ofFrontiers in microbiology · 2023Article
- The Efficacy of Using Combination Therapy against Multi-Drug and Extensively Drug-ResistantAntibiotics (Basel, Switzerland) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors at 10 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMDR bacteria including carbapenem-resistant
methodsWe conducted WGS and phylogenetic analysis of 72 carbapenem-resistant
resultsWe identified three variants of IMP gene, among which
conclusionsOur results provide evidence that not only
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.